1. Home
  2. XLO vs ASYS Comparison

XLO vs ASYS Comparison

Compare XLO & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • ASYS
  • Stock Information
  • Founded
  • XLO 2016
  • ASYS 1981
  • Country
  • XLO United States
  • ASYS United States
  • Employees
  • XLO N/A
  • ASYS N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • ASYS Industrial Machinery/Components
  • Sector
  • XLO Health Care
  • ASYS Technology
  • Exchange
  • XLO Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • XLO 42.2M
  • ASYS 49.8M
  • IPO Year
  • XLO 2021
  • ASYS N/A
  • Fundamental
  • Price
  • XLO $1.07
  • ASYS $4.01
  • Analyst Decision
  • XLO Buy
  • ASYS
  • Analyst Count
  • XLO 1
  • ASYS 0
  • Target Price
  • XLO $4.00
  • ASYS N/A
  • AVG Volume (30 Days)
  • XLO 2.9M
  • ASYS 81.5K
  • Earning Date
  • XLO 05-08-2025
  • ASYS 05-12-2025
  • Dividend Yield
  • XLO N/A
  • ASYS N/A
  • EPS Growth
  • XLO N/A
  • ASYS N/A
  • EPS
  • XLO N/A
  • ASYS N/A
  • Revenue
  • XLO $9,274,000.00
  • ASYS $90,826,000.00
  • Revenue This Year
  • XLO $299.61
  • ASYS N/A
  • Revenue Next Year
  • XLO $1.99
  • ASYS $28.60
  • P/E Ratio
  • XLO N/A
  • ASYS N/A
  • Revenue Growth
  • XLO N/A
  • ASYS N/A
  • 52 Week Low
  • XLO $0.62
  • ASYS $3.20
  • 52 Week High
  • XLO $1.70
  • ASYS $6.96
  • Technical
  • Relative Strength Index (RSI)
  • XLO 64.52
  • ASYS 54.53
  • Support Level
  • XLO $0.86
  • ASYS $3.62
  • Resistance Level
  • XLO $0.92
  • ASYS $4.24
  • Average True Range (ATR)
  • XLO 0.11
  • ASYS 0.24
  • MACD
  • XLO 0.02
  • ASYS 0.08
  • Stochastic Oscillator
  • XLO 77.18
  • ASYS 75.00

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: